RX-1001

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRX-1001
Drug Alias Namethymidine synthase inhibitor (Rexahn)RX-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpus Genetics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A